ARTICLE | Company News
Nektar, AstraZeneca deal
September 28, 2009 7:00 AM UTC
Nektar granted AstraZeneca exclusive, worldwide rights to NKTR-118 and NKTR-119. Nektar will receive $125 million up front and could receive $610 million in milestones for NKTR-118 and $385 million ...